Alkermes Investigational Site

Houston, Texas 77098

0 studies enrolling now · 14 studies all time

What they study most

Alcohol Dependence, Bipolar I Disorder, Major Depressive Disorder, Multiple Sclerosis, OIC, Relapsing Remitting Multiple Sclerosis, Schizophrenia, Schizophreniform Disorder, Schizophreniform Disorders

Studies at this site

• Study to Evaluate the Long-term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831 — Completed
• Observational Study of Long Acting Injectable Medications (LAIs) in Schizophrenia (OASIS) — Completed
• Study to Evaluate the Efficacy of ALKS 3831 on Body Weight in Young Adults Who Have Been Recently Diagnosed With Schizophrenia, Schizophreniform, or Bipolar I Disorder — Completed
• A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1 — Completed
• A Study of ALKS 3831 in Adults With Schizophrenia — Completed
• A Phase 3, Long-term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia — Completed
• A Tolerability Study of ALKS 8700 in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS) EVOLVE-MS-2 — Completed
• A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study) — Completed
• A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-4 Study — Completed
• A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-3 Study — Completed
• A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD) — Completed
• A Long-Term Safety Study of ALKS 5461 — Completed
• ALK37-007: Evaluation of Safety and Efficacy of ALKS 37 (RDC-1036) in Adults With Opioid-induced Constipation (OIC) — Completed
• ALK33-005: A Study of ALKS33 (RDC-0313) in Adults With Alcohol Dependence — Completed